Davis P L, Anderson J P, Roberts E F. "一种利那洛肽杂质21的合成方法" [P]. US Patent, US 11804027 B2, 2025-07-27.
Nielsen H, Sørensen M, Schröder R. "Method for the Synthesis of Linaclotide Impurity 21" [P]. European Patent, EP 3743766 A1, 2018-03-26.
发明人李文辉,张德明,钱学锋. "A Process for Preparing High-Purity Linaclotide Impurity 21" [P]. 中国发明专利, 专利号 CN 113835018 A, 授权公告日 2024-07-13.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 利那洛肽杂质21 in Pharmaceutical Formulations". Molecules, 2017, 2308, 724-745.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利那洛肽杂质21 as an Impurity". Chromatographia, 2024, 2008, 2887-2892.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Linaclotide Impurity 21 Using HRMS and NMR". Biomed. Chromatogr., 2011, 2001, (12), 3495-3504.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 利那洛肽杂质21 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2025, 2407, 3647-3676.